PRIMARY OBJECTIVE:~I. To evaluate the feasibility of using EMBr Wave technology in women with a history of breast cancer who are experiencing bothersome hot flashes.~SECONDARY OBJECTIVES:~I. To evaluate the preliminary efficacy of EMBr Wave in reducing hot flash severity and frequency in women with a history of breast cancer.~II. To identify in what ways EMBr Wave has the greatest potential efficacy, such as reduction in vasomotor symptoms (VMS) severity, frequency, duration, sense of control, or self-esteem.~III. To estimate effect sizes to inform power calculations for a future phase III trial.~OUTLINE: Patients are randomized to 1 of 2 arms.~ARM A: Patients utilize the EMBr Wave device for 4 weeks, then crossover to arm B for 4 weeks.~ARM B: Patients receive no treatment for 4 weeks, then crossover to arm A for 4 weeks.
This trial studies how well EMBr Wave technology works in reducing hot flashes in women with a history of breast cancer. Hot flashes are a common symptom experienced by menopausal women. The standard treatment for hot flashes is hormone replacement therapy, however hormone replacement therapy cannot be used in women with a history of, or active, breast cancer. EMBr Wave is a personal heating and cooling device worn on the wrist. EMBr Wave may help reduce hot flash severity in women with a history of breast cancer.